Melaleuca CellWise and Other Vitamin Complexes May Help Fight
Cancer | Benzinga
http://www.benzinga.com/pressreleases/12/09/p2948042/melaleuca-cellwise-and-other-vitamin-complexes-may-help-fight-cancer[10/14/15,
1:42:54 PM]
EUR/USD1.1446
+0.0065+0.57%
Dow16,984.00
-0.98-0.57%
S&P 5002,000.75
-2.94-0.15%
NASDAQ4,804.48
+7.87+0.16%
30yr T-Bond2.85
-0.04-1.52%
Melaleuca CellWise and Other Vitamin Complexes May Help Fight
Cancer PRWeb FOLLOW
September 27, 2012 5:50pm Comments
Melaleuca's new vitamin and mineral complexes contain high
amounts of antioxidants which studies have shown play a large part
in the prevention of cellular damage and the occurrence of
cancer.
San Diego, CA (PRWEB) September 27, 2012
Melaleuca, a wellness company that is named after a genus of
Australian medicinal plants, has developed a patented anti-oxidant
formula which may be able to help fight cancer. While the company
is known for its concentrated eco-friendly cleaning products, it is
also known for its development of many vitamin and mineral
supplements.
One of the most promising formulas they have developed, in
regards to cancer fighting abilities, is the broad spectrum
antioxidant, CellWise. This complex contains both vitamin C (a
powerful antioxidant) and Oglio, which is Melaleuca's patented
formula that protects minerals. These combine to help reduce excess
free radicals. Damage by free radicals, according to the National
Cancer Institute, is what causes the occurrence of cancerous cells.
Antioxidants help to protect against this damage, and even reverse
it, by preventing the generation of free radicals in the body.
Aside from CellWise there are also other vitamin complexes in
the Melaleuca line which could be useful in the prevention of
cancer. The Vitality MultiVitamin and Supplement contains
beta-carotene, vitamins C and E, and the mineral
selineum, all of which improve the functioning of the immune
system and protect against free radicals.
Melaleuca's Vitality Calcium Complete, a calcium and vitamin D
complex, is also purported to help keep your immune system healthy,
as it provides a natural source of vitamin D. Usually, we get this
vitamin in small amounts from the foods we eat; in things like
eggs, milk and fish. However, one of the main sources of vitamin D
is what we get when we are exposed to the UVB rays of the sun.
While in small amounts, this has no harmful affects, too much sun
exposure will also result in the development of free radicals. As
such,
Benzinga Benzinga Pro Marketfy Financial Data & APIs Free
Streaming News Contribute Login Sign Up
Trending Recent
Join TD Ameritrade. Get up to $600 and trade FREE for 60
days.
Get Benzinga's Newsletters
1 TEVA, AGN: Pfizer, Allergan Shares Pop After Buyout Rumor2
FIT: These Fitbit Numbers Make The Stock A Screaming Buy3 NFLX: Bob
Peck: Netflix Worth $110 Sum-Of-Parts, But Be Cautious Of In...4
JPM, WFC: Keep an Eye on These 10 Stocks for October 14, 20155 GLD,
CVX: Jim Cramer Gives His Opinion On SPDR Gold Trust,...6 DELL,
VMW: PacCrest's Owens Sees 'Many Q...7 October 13 Earnings
Update
Home News Markets Ratings Ideas Tech Small-Cap Personal Finance
Premium ProductsMy Watchlist
News Markets Ratings Ideas Tech Small-Cap Personal Finance
Premium Products
http://www.facebook.com/pages/Benzingacom/159483118580?v=app_7146470109http://twitter.com/benzingahttp://www.linkedin.com/company/benzingahttps://plus.google.com/108838891574408087738/postshttp://feeds.benzinga.com/benzingahttp://www.benzinga.com/http://www.benzinga.com/users/prwebhttp://trustedhomebusinessreviews.com/melaleuca/http://www.benzinga.com/http://pro.benzinga.com/http://marketfy.com/http://cloud.benzinga.com/http://www.benzinga.com/widgets/live-updateshttp://www.benzinga.com/contributehttp://www.benzinga.com/userhttp://www.benzinga.com/userjavascript:void(0)javascript:void(0)javascript:void(0)javascript:void(0)https://adclick.g.doubleclick.net/aclk?sa=L&ai=BPigAgpIeVsc8xYAxwJ2e4AyLmLb3BwAAABABIAA4AFjLgIWJigJgyYaAgNCj2BCCARdjYS1wdWItNTY0OTg5NDg4OTUzNzcxOLIBEHd3dy5iZW56aW5nYS5jb226AQlnZnBfaW1hZ2XIAQnaAXlodHRwOi8vd3d3LmJlbnppbmdhLmNvbS9wcmVzc3JlbGVhc2VzLzEyLzA5L3AyOTQ4MDQyL21lbGFsZXVjYS1jZWxsd2lzZS1hbmQtb3RoZXItdml0YW1pbi1jb21wbGV4ZXMtbWF5LWhlbHAtZmlnaHQtY2FuY2VywAIC4AIA6gIcLzUyMDYvaW52Yy5iZW56aW5nYS9lcXVpdGllc_gChNIekAPgA5gD4AOoAwHQBJBO4AQBkAYBoAYg2AcA&num=0&cid=5GhgHhB0CiSnTpiqGGVLi81z&sig=AOD64_1l0qsd5_zcUtMPZny-yOYljxiR5A&client=ca-pub-5649894889537718&adurl=https://ad.doubleclick.net/ddm/clk/292548482;119665068;vhttps://adclick.g.doubleclick.net/aclk?sa=L&ai=BPigAgpIeVsc8xYAxwJ2e4AyLmLb3BwAAABABIAA4AFjLgIWJigJgyYaAgNCj2BCCARdjYS1wdWItNTY0OTg5NDg4OTUzNzcxOLIBEHd3dy5iZW56aW5nYS5jb226AQlnZnBfaW1hZ2XIAQnaAXlodHRwOi8vd3d3LmJlbnppbmdhLmNvbS9wcmVzc3JlbGVhc2VzLzEyLzA5L3AyOTQ4MDQyL21lbGFsZXVjYS1jZWxsd2lzZS1hbmQtb3RoZXItdml0YW1pbi1jb21wbGV4ZXMtbWF5LWhlbHAtZmlnaHQtY2FuY2VywAIC4AIA6gIcLzUyMDYvaW52Yy5iZW56aW5nYS9lcXVpdGllc_gChNIekAPgA5gD4AOoAwHQBJBO4AQBkAYBoAYg2AcA&num=0&cid=5GhgHhB0CiSnTpiqGGVLi81z&sig=AOD64_1l0qsd5_zcUtMPZny-yOYljxiR5A&client=ca-pub-5649894889537718&adurl=https://ad.doubleclick.net/ddm/clk/292548482;119665068;vhttp://www.benzinga.com/general/biotech/15/10/5908955/pfizer-allergan-shares-pop-after-buyout-rumorhttp://www.benzinga.com/general/biotech/15/10/5908955/pfizer-allergan-shares-pop-after-buyout-rumorhttp://www.benzinga.com/general/biotech/15/10/5908955/pfizer-allergan-shares-pop-after-buyout-rumorhttp://www.benzinga.com/general/biotech/15/10/5908955/pfizer-allergan-shares-pop-after-buyout-rumorhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908223/these-fitbit-numbers-make-the-stock-a-screaming-buyhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908223/these-fitbit-numbers-make-the-stock-a-screaming-buyhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908223/these-fitbit-numbers-make-the-stock-a-screaming-buyhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908223/these-fitbit-numbers-make-the-stock-a-screaming-buyhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5907912/bob-peck-netflix-worth-110-sum-of-parts-but-be-cautious-http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5907912/bob-peck-netflix-worth-110-sum-of-parts-but-be-cautious-http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5907912/bob-peck-netflix-worth-110-sum-of-parts-but-be-cautious-http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5907912/bob-peck-netflix-worth-110-sum-of-parts-but-be-cautious-http://www.benzinga.com/news/earnings/15/10/5911056/keep-an-eye-on-these-10-stocks-for-october-14-2015http://www.benzinga.com/news/earnings/15/10/5911056/keep-an-eye-on-these-10-stocks-for-october-14-2015http://www.benzinga.com/news/earnings/15/10/5911056/keep-an-eye-on-these-10-stocks-for-october-14-2015http://www.benzinga.com/news/earnings/15/10/5911056/keep-an-eye-on-these-10-stocks-for-october-14-2015http://www.benzinga.com/media/cnbc/15/10/5906591/jim-cramer-gives-his-opinion-on-spdr-gold-trust-randgold-resources-chevron-http://www.benzinga.com/media/cnbc/15/10/5906591/jim-cramer-gives-his-opinion-on-spdr-gold-trust-randgold-resources-chevron-http://www.benzinga.com/media/cnbc/15/10/5906591/jim-cramer-gives-his-opinion-on-spdr-gold-trust-randgold-resources-chevron-http://www.benzinga.com/media/cnbc/15/10/5906591/jim-cramer-gives-his-opinion-on-spdr-gold-trust-randgold-resources-chevron-http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908346/paccrests-owens-sees-many-questions-for-vmware-nowhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908346/paccrests-owens-sees-many-questions-for-vmware-nowhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908346/paccrests-owens-sees-many-questions-for-vmware-nowhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908346/paccrests-owens-sees-many-questions-for-vmware-nowhttp://www.benzinga.com/trading-ideas/previews/15/10/5643986/october-13-earnings-updatehttp://www.benzinga.com/trading-ideas/previews/15/10/5643986/october-13-earnings-updatehttp://www.benzinga.com/http://www.benzinga.com/newshttp://www.benzinga.com/marketshttp://www.benzinga.com/analyst-ratingshttp://www.benzinga.com/trading-ideashttp://www.benzinga.com/techhttp://www.benzinga.com/news/small-caphttp://www.benzinga.com/personal-financehttp://marketfy.com/http://www.benzinga.com/userhttp://www.benzinga.com/newshttp://www.benzinga.com/marketshttp://www.benzinga.com/analyst-ratingshttp://www.benzinga.com/trading-ideashttp://www.benzinga.com/techhttp://www.benzinga.com/news/small-caphttp://www.benzinga.com/personal-financehttp://marketfy.com/http://www.benzinga.com/TINAHighlight
TINAHighlight
TINAHighlight
TINAHighlight
Melaleuca CellWise and Other Vitamin Complexes May Help Fight
Cancer | Benzinga
http://www.benzinga.com/pressreleases/12/09/p2948042/melaleuca-cellwise-and-other-vitamin-complexes-may-help-fight-cancer[10/14/15,
1:42:54 PM]
the vitamin complex offers a safe and natural way to obtain this
nutrient.
While Frank Vandersloot, the founder of Melaleuca, ensures that
all products that are produced are 100% safe and of the highest
quality, the claims about the vitamin complexes are not FDA tested.
However, studies have shown that having a healthy lifestyle, which
is supplemented with a quality diet and consumption of antioxidants
in foods and supplement form, can help prevent the occurrence of
cancer and many other preventable diseases. A full Melaleuca review
gives more information on the company.
For the original version on PRWeb visit:
http://www.prweb.com/releases/prwebmelaleuca/cellwise/prweb9944953.htm
View Comments and Join the Discussion!
View upcoming Earnings, Ratings, Dividend and Economic
Calendars.
01:29 PM Nike Issues Release Confirming $50B in Sales by End of
FY2020
1:28 PM Nike Issues Release Confirming $50B in Sales by End of
FY2020
1:27 PM Lockheed Martin Shares Seeing Selling Pressure,
Currently At LOD Of $210.63
1:25 PM UPDATE: MKM Analyst on EA Upgrade: 'Higher Star Wars:
Battlefront Expectations Driving FY16 Estimates Higher'
http://trustedhomebusinessreviews.com/melaleuca/http://trustedhomebusinessreviews.com/melaleuca/http://www.prweb.com/releases/prwebmelaleuca/cellwise/prweb9944953.htmhttp://limited.benzinga.com/bzcom/?utm_campaign=Benzinga&utm_medium=-&utm_source=Unbounce&utm_content=onedollarhttp://limited.benzinga.com/bzcom/?utm_campaign=Benzinga&utm_medium=-&utm_source=Unbounce&utm_content=onedollarhttp://www.benzinga.com/calendar/earningshttp://www.benzinga.com/calendar/earningshttp://www.benzinga.com/news/15/10/5913274/nike-issues-release-confirming-50b-in-sales-by-end-of-fy2020http://www.benzinga.com/news/15/10/5913274/nike-issues-release-confirming-50b-in-sales-by-end-of-fy2020http://www.benzinga.com/news/15/10/5913271/nike-issues-release-confirming-50b-in-sales-by-end-of-fy2020http://www.benzinga.com/news/15/10/5913271/nike-issues-release-confirming-50b-in-sales-by-end-of-fy2020http://www.benzinga.com/movers/15/10/5913268/lockheed-martin-shares-seeing-selling-pressure-currently-at-lod-of-210-63http://www.benzinga.com/movers/15/10/5913268/lockheed-martin-shares-seeing-selling-pressure-currently-at-lod-of-210-63http://www.benzinga.com/movers/15/10/5913268/lockheed-martin-shares-seeing-selling-pressure-currently-at-lod-of-210-63http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5913266/update-mkm-analyst-on-ea-upgrade-higher-star-wars-battlehttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5913266/update-mkm-analyst-on-ea-upgrade-higher-star-wars-battlehttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5913266/update-mkm-analyst-on-ea-upgrade-higher-star-wars-battle
Melaleuca CellWise and Other Vitamin Complexes May Help Fight
Cancer | Benzinga
http://www.benzinga.com/pressreleases/12/09/p2948042/melaleuca-cellwise-and-other-vitamin-complexes-may-help-fight-cancer[10/14/15,
1:42:54 PM]
1 (877) 440-9464 (ZING) © Copyright Benzinga
Benzinga is a fast-growing, dynamic and innovative financial
media outlet that empowers investors with high-quality, unique
content.
Analyst Ratings
Be Your Own Boss
ETFs
Economics
Forex
Hot
News
Options
Press Releases
Start-ups
Tech
Popular Channels
Affiliate Program
Feeds
News Widget
Real Time Feed
Sitemap
Submit News Tips
Tools & Features
About Us
Licensing and APIs
Apps (iOS and Android)
Fintech Awards
Blog
In the News
Careers
Contact Us
Disclaimer
Privacy Policy
Syndication
Terms and Conditions
About Benzinga Benzinga Partners
http://www.benzinga.com/analyst-ratingshttp://www.benzinga.com/be-your-own-bosshttp://www.benzinga.com/etfshttp://www.benzinga.com/economicshttp://www.benzinga.com/markets/forexhttp://www.benzinga.com/hothttp://www.benzinga.com/newshttp://www.benzinga.com/markets/optionshttp://www.benzinga.com/pressreleaseshttp://www.benzinga.com/startupshttp://www.benzinga.com/techhttp://benzinga.postaffiliatepro.com/affiliateshttp://www.benzinga.com/feeds/listhttp://www.benzinga.com/partners/widgetshttp://www.benzinga.com/widgets/live-updateshttp://www.benzinga.com/sitemaphttp://www.benzinga.com/contacthttp://www.benzinga.com/abouthttp://cloud.benzinga.com/http://www.benzinga.com/appshttp://benzingafintechawards.com/http://www.benzinga.com/bloghttp://www.benzinga.com/inthenewshttp://jobs.benzinga.com/http://www.benzinga.com/contacthttp://www.benzinga.com/disclaimerhttp://www.benzinga.com/page/privacyhttp://www.benzinga.com/syndicationhttp://www.benzinga.com/terms-and-conditions
benzinga.comMelaleuca CellWise and Other Vitamin Complexes May
Help Fight Cancer | Benzinga
1heS1oZWxwLWZpZ2h0LWNhbmNlcgA=: form0: button7: query: Tickers,
Articles & Keywords
1heS1oZWxwLWZpZ2h0LWNhbmNlcgA=: button5:
1heS1oZWxwLWZpZ2h0LWNhbmNlcgA=: form1: email_id: Email
Addressop: